Inflammatory bowel diseases: meeting of the European Crohn’s Colitis Organization

Abstract

Inflammatory bowel diseases affect > 1 million Europeans, and mostly people at a young age. Although these diseases are still increasing worldwide, especially in children and adolescents, progress in the pathophysiology and treatment of these diseases in recent years has been tremendous. In particular, anti-TNF-α agents dramatically changed the management of these diseases. The European Crohn’s Colitis Organization recently held its second annual meeting in Innsbruck, Austria dealing with both new basic and clinical developments in the field.

Keywords::

• anti-TNF agent
• Crohn’s disease
• TNF-α
• ulcerative colitis